Boca Raton, FL -- (SBWIRE) -- 08/20/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners.StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks – BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Pain Therapeutics, Inc. (NASDAQ:PTIE), Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), Beazer Homes USA, Inc. (NYSE:BZH)
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) opened the session at $5.44, remained amid the day range of $5.35 - $5.64, and closed the session at $5.48. The stock gained a volume of 1.32 million shares and the average volume of the stock remained 3.71 million shares. BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on therapeutic areas.
Can Investors Bet on BCRX after this News update? F ind out in this Research Report
Pain Therapeutics, Inc. (NASDAQ:PTIE) traded with volume of 1.31 million shares in the prior session and the average volume of the stock remained 365,588.00 shares. The 52 week range of the stock remained $2.15 - $5.86. The stock showed a negative movement of -7.07% and closed its session at $2.89. The market capitalization of the stock remained 131.32 million. Pain Therapeutics, Inc. is a biopharmaceutical company that develops drugs. The Company has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma.
Has PTIE Found The Bottom And Ready To Gain Momentum? Find Out Here
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) exchanged 1.32 million shares and the average volume remained 890,653.00 shares. The stock escalated 2.68% and closed the session at $17.25. The beta of the stock remained 0.87 and the EPS of the stock remained 2.60. The shares outstanding of the stock remained 49.39 million. Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company focuses on developing and marketing products to predominantly specialist audiences. It market two products: Testim testosterone gel and XIAFLEX (collagenase clostridium histolyticum).
Will AUXL Continue To Move Higher? Find Out Here
Beazer Homes USA, Inc. (NYSE:BZH) gained volume of 1.30 million shares, while the average volume remained 1.01 million shares. The stock decreased -5.24% and finished the session Monday at $16.47. The EPS of the stock remained -6.04. The one month of the stock was -10.83% and three month trend remained negative -25.98%.Beazer Homes USA, Inc. (Beazer) diversified homebuilder with active operations in 16 states. In the Company’s homebuilding operations, it designs, sells and builds single-family and multi-family homes. During the fiscal year ended September 30, 2011(fiscal 2011).
Will BZH Get Buyers Even After The Recent Rally? Find Out Here
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)